Home
Conditions
Skin Diseases, Vesiculobullous

Clinical trial condition

Skin Diseases, Vesiculobullous

Explore clinical trials studying Skin Diseases, Vesiculobullous. Study availability and eligibility vary by location and protocol.

235 public trials 35 recruiting studies

Refine in advanced search Browse all conditions

Skin Diseases, Vesiculobullous trial results

Completed

Visual Distraction as a Means of Enhancing Child Resistance

NCT01859780

Conditions: Blister, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, +4 more
Locations: Packaging Building East Lansing, Michigan, United States

LESA Early Childhood Programs Howell, Michigan, United States

Great Lakes Marketing Toledo, Ohio, United States

View Trial Details

Completed

Study of Cellutome System for Treatment of Individual Lesions in EB Pts

NCT02670837

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Epidermolysis Bullosa, +6 more
Locations: University of Minnesota Masonic Cancer Center and Medical Center Minneapolis, Minnesota, United States

View Trial Details

Completed

A Long-term Treatment With B-VEC for Dystrophic Epidermolysis Bullosa

NCT04917874

Conditions: Collagen Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +13 more
Locations: Mission Dermatology Center Rancho Santa Margarita, California, United States

Stanford University Redwood City, California, United States

Pediatric Skin Research Coral Gables, Florida, United States

Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Biochemical Correction of Severe EB by Allo HSCT and "Off-the-shelf" MSCs

NCT01033552

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Epidermolysis Bullosa, +6 more
Locations: University of Minnesota Masonic Cancer Center and Medical Center Minneapolis, Minnesota, United States

View Trial Details

Completed

Safety, Tolerability, and Pharmacokinetics of Ascending Topical Doses of TCP-25 Applied to Epidermal Suction Blister Wounds, Non-Healing Leg Ulcers and Patients With Dystrophic Epidermolysis Bullosa.

NCT05378997

Conditions: Blister, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +11 more
Locations: Skåne University Hospital in Lund, Clinical Trial Unit Lund, Sweden

View Trial Details

Completed

M. Hailey-Hailey: hSPCA1 Expression and Skin Structure Upon Laser Therapy

NCT03849989

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Hailey Hailey Disease, +5 more
Locations: Maastricht University Medical Center Maastricht, Limburg, Netherlands

View Trial Details

Completed

Observational Study Assessing Outcomes, Treatment Patterns and Related Costs in Patients in Bullous Pemphigoid

NCT02837965

Conditions: Autoimmune Diseases, Bullous Pemphigoid, Immune System Diseases, +4 more
Locations: Chu Reims Reims, France

View Trial Details

Completed

Vitamin D Levels in Non-immediate Drug Hypersensitivity Case-control Study

NCT06263140

Conditions: Avitaminosis, Chemically-Induced Disorders, Deficiency Diseases, +24 more
Locations: Faculty of Medicine, Chulalongkorn University Bangkok, Thailand

View Trial Details

Completed

Dexamethasone Solution and Dexamethasone in Mucolox™

NCT04540133

Conditions: Autoimmune Diseases, Bronchial Diseases, Bronchiolitis, +26 more
Locations: Sol Silverman Oral Medicine Clinic - UCSF San Francisco, California, United States

View Trial Details

Completed

Identifying Factors Influencing In-Hospital Relapse in Pemphigus Patients

NCT06167408

Conditions: Autoimmune Diseases, Immune System Diseases, Pemphigus, +4 more
Locations: First Affiliated hospital of Chongqing Medical University Chongqing, Yuzhong District, China

View Trial Details

Skin Diseases, Vesiculobullous

Skin Diseases, Vesiculobullous trial results

Related conditions